Wayne Fields

Wayne Fields serves as a key procurement lead within the Office of the Assistant Secretary for Preparedness and Response, supporting the Department of Health and Human Services’ mission to secure and deploy medical countermeasures against public health emergencies. He manages acquisition strategies for advanced biodefense technologies, including vaccines, therapeutics, and diagnostic platforms, ensuring rapid responsiveness to emerging biological threats. His work directly enables the agency’s goal of maintaining a resilient national medical supply chain through timely, scientifically informed contracting actions that prioritize innovation and scalability. Fields maintains consistent procurement relationships with specialized biopharmaceutical and advanced delivery technology firms, including Cidara Therapeutics, Aquestive Therapeutics, Rafah Laboratories, and Osivax. These partnerships center on the development and manufacturing of novel antivirals, sustained-release formulations, and platform-based vaccine candidates. His contracting approach emphasizes performance-based requirements, technology readiness assessments, and early-stage collaboration with vendors to accelerate product development timelines under BARDA’s unique authority to support high-risk, high-reward medical countermeasure pipelines. Fields’ procurement portfolio reflects a strict focus on non-set-aside awards, with 100% of contracts awarded under unrestricted competition. This indicates a strategic prioritization of technical capability and speed over socioeconomic preferences, aligning with BARDA’s emergency response imperatives where proven, scalable solutions take precedence over certification-based contracting pathways. His primary procurement activity is classified under NAICS 112990—All Other Animal Production—reflecting a critical, though non-obvious, focus on the production of animal-derived biological materials used in vaccine development, cell culture media, and diagnostic reagents. This specialization underscores his deep technical understanding of the supply chain underpinnings of biomanufacturing, particularly in sourcing raw biological inputs essential for countermeasure production. His expertise lies at the intersection of regulatory compliance, biosafety standards, and industrial-scale bioprocessing logistics.